Fri, Jan 05, 2024
At noon, the stock was off the 52-week high and trading with a cut of 0.5 per cent for the day at Rs 1,390.3 apiece on the bourse.
More >
Tue, Jan 02, 2024
At around 9:55 a.m., shares of Lupin traded up by 4.51 per cent or Rs 59.2 at Rs 1371.85 apiece. The market capitalisation of the pharmaceutical company stood at Rs 62,457.14 crore at the same time.
Fri, Dec 22, 2023
Lupin Atlantis Holdings SA, Switzerland, a wholly-owned subsidiary of the company, has signed an asset purchase agreement with Sanofi, a French multinational pharmaceutical and healthcare company, for the purpose, Lupin said in a regulatory filing.
Wed, Jul 12, 2023
The share price of the global pharma major hit a 52-week high of Rs 943.10 on the BSE on Wednesday.
Mon, May 08, 2023
Lupin Q4 result preview: The chemical company’s profit after tax (PAT) is expected at Rs 167 crore compared to a loss of Rs 512 crore reported in the year-ago period.
Thu, Mar 30, 2023
In November last year, USFDA had issued Form-483 with eight observations each for product and raw material production centres at Lupin's Mandideep-based manufacturing facility.
Thu, Nov 10, 2022
Lupin Share Price: The drug maker on Wednesday said its consolidated net profit stood at Rs 130 crore for the second quarter ended September 30, 2022.
Fri, Oct 29, 2021
We have collated a list of views from various global brokerage on Lupin, Indigo, Marico, Gujarat Gas, and SBI Cards that came out with results on Thursday.
Thu, Aug 12, 2021
The stock on Wednesday had declined by around 7 per cent to its intraday low on the back of good, but lower than expected Q1 numbers.
Tue, Feb 06, 2018
Lupin's consolidated PAT more than halved in Q3FY18 to Rs 221.7 crore, down by 65% from Rs 633.1 crore, in the corresponding period of the previous year.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
